Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR11980(B)] to Opticin
- Suitable for: WB, ICC/IF
- Reacts with: Mouse, Rat, Human
Product nameAnti-Opticin antibody [EPR11980(B)]
See all Opticin primary antibodies
DescriptionRabbit monoclonal [EPR11980(B)] to Opticin
Tested applicationsSuitable for: WB, ICC/IFmore details
Unsuitable for: Flow Cyt,IHC or IP
Species reactivityReacts with: Mouse, Rat, Human
Synthetic peptide within Human Opticin aa 1-100 (Cysteine residue). The exact sequence is proprietary.
Database link: Q9UBM4
- Y79 cells and cell lysates; Fetal heart lysate; A431 cell lysates.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant
Concentration information loading...
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab170886 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Predicted molecular weight: 37 kDa.|
|ICC/IF||1/100 - 1/250.|
FunctionBinds collagen fibrils.
Tissue specificityRetina, iris, ligament, skin and fetal liver.
Sequence similaritiesBelongs to the small leucine-rich proteoglycan (SLRP) family. SLRP class III subfamily.
Contains 6 LRR (leucine-rich) repeats.
Contains 1 LRRNT domain.
Cellular localizationSecreted > extracellular space > extracellular matrix.
- Information by UniProt
- Oculoglycan antibody
- OPT antibody
- OPT_HUMAN antibody
Immunofluorescent analysis of Y79 cells labeling Opticin with ab170886 at 1/100 dilution (green). DAPI nuclear staining (blue).
All lanes : Anti-Opticin antibody [EPR11980(B)] (ab170886) at 1/1000 dilution
Lane 1 : Fetal heart lysate
Lane 2 : Y79 lysate
Lane 3 : A431 lysate
Lysates/proteins at 10 µg per lane.
All lanes : Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 37 kDa
ab170886 has been referenced in 1 publication.
- Fincham GS et al. Posterior Vitreous Detachment and the Posterior Hyaloid Membrane. Ophthalmology 125:227-236 (2018). PubMed: 28867131